Moderna, Inc. (MRNA) /

The profitability of Moderna, Inc. over the past 10 years

Chart Moderna, Inc.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →

Moderna, Inc. reported a net loss of $2.82B in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $1.08B and an operating loss of $3.07B. It reported a profit in 2 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019, 2020, 2023, 2024 and 2025. Its highest net income in these years was $12.2B, in fiscal 2021.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025$1.08B*-$3.07B-$2.82B
2024ended Dec 31, 2024$1.77B*-$3.94B-$3.56B
2023ended Dec 31, 2023$2.15B*-$4.24B-$4.71B
2022ended Dec 31, 2022$13.85B*$9.42B$8.36B
2021ended Dec 31, 2021$15.85B*$13.3B$12.2B
2020ended Dec 31, 2020$795M*-$763M-$747M
2019ended Dec 31, 2019$60M*-$546M-$514M
2018ended Dec 31, 2018$135.07M*-$413.27M-$384.73M
2017ended Dec 31, 2017—-$269.36M-$255.92M
2016ended Dec 31, 2016—-$223.77M-$216.2M

Fiscal years as Moderna, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on Moderna, Inc.

Companies of a similar size

Not investment advice. This page shows what Moderna, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.